Neoplasm

Oncology·MeSH: Neoplasms

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

371 drugs in development·69 companies·7 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
elzonris	STEMLINE THERAPEUTICS INC (STML)
levoleucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
zaltrap	Sanofi (SNY)

Phase 3(124)

Drug	Company
177lu-psma-617	Novartis AG (NVS)
177Lu-PSMA-617	Novartis AG (NVS)
5-fu	PFIZER INC (PFE)
abiraterone	GH Research PLC (GHRS)
abiraterone	CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
Abiraterone acetate	Merck & Co., Inc. (MRK)
Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
Acetaminophen	Merck & Co., Inc. (MRK)
adt	Novartis AG (NVS)
Alpelisib	Relay Therapeutics, Inc. (RLAY)
Amivantamab	REGENXBIO Inc. (RGNX)
Amivantamab	Amneal Pharmaceuticals, Inc. (AMRX)
Amivantamab and Recombinant Human Hyaluronidase	Amneal Pharmaceuticals, Inc. (AMRX)
Androgen-deprivation Therapy	Myovant Sciences Ltd. (MYOV)
Apalutamide	Myovant Sciences Ltd. (MYOV)
Apalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Apalutamide 60 mg or 240 mg tablets	KYNTRA BIO INC. (KYNB)
ardt	Novartis AG (NVS)
ARDT	Novartis AG (NVS)
arpi	Novartis AG (NVS)
AZD2962	ASTRAZENECA PLC (AZN)
Belrestotug	iTeos Therapeutics, Inc. (ITOS)
belrestotug (EOS-448/GSK4428859A)	iTeos Therapeutics, Inc. (ITOS)
bezuclastinib (CGT9486)	Cogent Biosciences, Inc. (COGT)
Bicalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Cabazitaxel	Merck & Co., Inc. (MRK)
Calderasib	Merck & Co., Inc. (MRK)
Camrelizumab and Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
cetrelimab	GH Research PLC (GHRS)
Cetrelimab	CG Oncology, Inc. (CGON)
Cetrelimab	KYNTRA BIO INC. (KYNB)
cetuximab	GH Research PLC (GHRS)
Cetuximab	REGENXBIO Inc. (RGNX)
Cetuximab	Merck & Co., Inc. (MRK)
Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
Conventional NSAA	KYNTRA BIO INC. (KYNB)
CPX-351	Jazz Pharmaceuticals plc (JAZZ)
Darolutamide	Merus N.V. (MRUS)
Darolutamide	ARS Pharmaceuticals, Inc. (SPRY)
Darolutamide	ELI LILLY & Co (LLY)
Dostarlimab	iTeos Therapeutics, Inc. (ITOS)
eflornithine plus sulindac	GH Research PLC (GHRS)
EGFR-TKI inhibitor based on investigator's choice	Relay Therapeutics, Inc. (RLAY)
eltanexor	Karyopharm Therapeutics Inc. (KPTI)
Enzalutamide	Myovant Sciences Ltd. (MYOV)
Epirubicin	Merck & Co., Inc. (MRK)
Epirubicin	Merus N.V. (MRUS)
Epirubicin Hydrochloride	Merck & Co., Inc. (MRK)
Erlotinib Hydrochloride	Amneal Pharmaceuticals, Inc. (AMRX)
fedratinib pill	GH Research PLC (GHRS)
Floxuridine	IGM Biosciences, Inc. (IGMS)
fludarabine phosphate	Filana Therapeutics Inc. (FLNA)
Fludrocortisone acetate	Merck & Co., Inc. (MRK)
folfiri	Sanofi (SNY)
folfiri	GH Research PLC (GHRS)
GnRH	ARS Pharmaceuticals, Inc. (SPRY)
GnRH Agonist	Myovant Sciences Ltd. (MYOV)
H1 receptor antagonist	Merck & Co., Inc. (MRK)
H2 receptor antagonist	Merck & Co., Inc. (MRK)
Hydrocortisone	Merck & Co., Inc. (MRK)
Imlunestrant + Goserelin	ELI LILLY & Co (LLY)
inca033989	Incyte Corp. (INCY)
inca035784	Incyte Corp. (INCY)
inca036978	Incyte Corp. (INCY)
infliximab	GH Research PLC (GHRS)
Intismeran autogene	Merck & Co., Inc. (MRK)
intravenous immunoglobulin therapy	GH Research PLC (GHRS)
Ivosidenib	AGIOS PHARMACEUTICALS, INC. (AGIO)
JAK Inhibitor	Assertio Holdings, Inc. (ASRT)
JNJ-56021927	ARS Pharmaceuticals, Inc. (SPRY)
jnj-78278343	GH Research PLC (GHRS)
jnj-86974680	GH Research PLC (GHRS)
jnj-87189401	GH Research PLC (GHRS)
leucovorin calcium/levoleucovorin	GH Research PLC (GHRS)
Leucovorin calcium/Levoleucovorin	REGENXBIO Inc. (RGNX)
LHRHa	Myovant Sciences Ltd. (MYOV)
LHRHA	KYNTRA BIO INC. (KYNB)
LY4064809	Merus N.V. (MRUS)
LY4064809	ELI LILLY & Co (LLY)
MIRV	ELI LILLY & Co (LLY)
MIRV	Merus N.V. (MRUS)
mitomycin c	GH Research PLC (GHRS)
MK-1084	Merck & Co., Inc. (MRK)
MMC	Merus N.V. (MRUS)
momelotinib	GH Research PLC (GHRS)
Neratinib Maleate	ENANTA PHARMACEUTICALS INC (ENTA)
Neratinib Maleate	Merus N.V. (MRUS)
Neratinib Maleate	Relay Therapeutics, Inc. (RLAY)
New Formulation of Niraparib and Abiraterone Acetate	Janux Therapeutics, Inc. (JANX)
New Formulation of Niraparib and Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
niraparib	GH Research PLC (GHRS)
Niraparib	Myovant Sciences Ltd. (MYOV)
Niraparib	Merus N.V. (MRUS)
Niraparib	Janux Therapeutics, Inc. (JANX)
Olaparib	Merck & Co., Inc. (MRK)
ONC206	Jazz Pharmaceuticals plc (JAZZ)
Opevesostat	Merck & Co., Inc. (MRK)
Panitumumab	ENANTA PHARMACEUTICALS INC (ENTA)
Panitumumab-IRDye800	ENANTA PHARMACEUTICALS INC (ENTA)
pasritamig	GH Research PLC (GHRS)
Patritumab deruxtecan	Merck & Co., Inc. (MRK)
Pemetrexed	KYNTRA BIO INC. (KYNB)
Pertuzumab	ASTRAZENECA PLC (AZN)
Pertuzumab	Merck & Co., Inc. (MRK)
platinum	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
platinum	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Remzistotug	iTeos Therapeutics, Inc. (ITOS)
Rescue Medications	Merck & Co., Inc. (MRK)
Sacituzumab tirumotecan	Merus N.V. (MRUS)
Sofetabart Mipitecan	Merus N.V. (MRUS)
Sofetabart Mipitecan	ELI LILLY & Co (LLY)
Standard Adjuvant Endocrine Therapy	PFIZER INC (PFE)
Tacrolimus	Filana Therapeutics Inc. (FLNA)
Taletrectinib	Nuvation Bio Inc. (NUVB)
tar-200	GH Research PLC (GHRS)
TAR-200	CG Oncology, Inc. (CGON)
TAR-200	Merus N.V. (MRUS)
tar-210	GH Research PLC (GHRS)
TAR-210	Merus N.V. (MRUS)
Temozolomide	BRISTOL MYERS SQUIBB CO (BMY)
Thiotepa	Filana Therapeutics Inc. (FLNA)
Tislelizumab	Jazz Pharmaceuticals plc (JAZZ)
Tucatinib	PFIZER INC (PFE)
Vinblastine	ASTRAZENECA PLC (AZN)

Phase 2(99)

Drug	Company
-endoxifen	ATOSSA THERAPEUTICS, INC. (ATOS)
350 mg leronlimab	CytoDyn Inc. (CYDY)
525 mg leronlimab	CytoDyn Inc. (CYDY)
68ga-psma-11	Novartis AG (NVS)
68Ga-PSMA-11	Novartis AG (NVS)
700 mg leronlimab	CytoDyn Inc. (CYDY)
aaa517	Novartis AG (NVS)
AAA517	Novartis AG (NVS)
Acetaminophen	Valneva SE (VALN)
ADT	Novartis AG (NVS)
Alpelisib	Merus N.V. (MRUS)
Alpelisib	ADMA BIOLOGICS, INC. (ADMA)
Alpelisib	ENANTA PHARMACEUTICALS INC (ENTA)
Apalutamide	ENANTA PHARMACEUTICALS INC (ENTA)
ARPI	Novartis AG (NVS)
AZD6738	UNITED THERAPEUTICS Corp (UTHR)
BCG	Merck & Co., Inc. (MRK)
Bezuclastinib	Cogent Biosciences, Inc. (COGT)
Binimetinib	Relay Therapeutics, Inc. (RLAY)
Binimetinib	ENANTA PHARMACEUTICALS INC (ENTA)
bridging therapy	GH Research PLC (GHRS)
Busulfan	Filana Therapeutics Inc. (FLNA)
Busulfan	Assertio Holdings, Inc. (ASRT)
Cabazitaxel	Janux Therapeutics, Inc. (JANX)
CAR BCMA-CD70-T cells	Merus N.V. (MRUS)
CAR BCMA-CD70-T cells	Filana Therapeutics Inc. (FLNA)
Cetrelimab	Royalty Pharma plc (RPRX)
Cetrelimab	Merus N.V. (MRUS)
cetuximab	PFIZER INC (PFE)
Copanlisib Hydrochloride	Relay Therapeutics, Inc. (RLAY)
Defactinib Hydrochloride	Relay Therapeutics, Inc. (RLAY)
disitamab vedotin	PFIZER INC (PFE)
Eribulin	BioNTech SE (BNTX)
Feladilimab	iTeos Therapeutics, Inc. (ITOS)
FID-007	Fulgent Genetics Inc. (FLGT)
Flotufolastat F18	Valneva SE (VALN)
Fludarabine	Assertio Holdings, Inc. (ASRT)
GnRH Agonist	Royalty Pharma plc (RPRX)
GnRH Agonist	Janux Therapeutics, Inc. (JANX)
GNRH-A Goserelin	ELI LILLY & Co (LLY)
goserelin	ELI LILLY & Co (LLY)
goserelin	ATOSSA THERAPEUTICS, INC. (ATOS)
GSK4428859A	iTeos Therapeutics, Inc. (ITOS)
GSK6097608	iTeos Therapeutics, Inc. (ITOS)
incb160058	Incyte Corp. (INCY)
Ipatasertib	Merus N.V. (MRUS)
Ipatasertib	Relay Therapeutics, Inc. (RLAY)
itacitinib	JOHNSON & JOHNSON (JNJ)
Iza-bren	Merus N.V. (MRUS)
JNJ-63723283	Janux Therapeutics, Inc. (JANX)
Larotrectinib Sulfate	Relay Therapeutics, Inc. (RLAY)
leucovorin	KYNTRA BIO INC. (KYNB)
Leucovorin	Relay Therapeutics, Inc. (RLAY)
Leucovorin	ADMA BIOLOGICS, INC. (ADMA)
Leucovorin Calcium	Relay Therapeutics, Inc. (RLAY)
Megestrol acetate/Medroxyprogesterone acetate	Merck & Co., Inc. (MRK)
Melphalan	Assertio Holdings, Inc. (ASRT)
MHA	Jazz Pharmaceuticals plc (JAZZ)
MK-4716	Merck & Co., Inc. (MRK)
morab-202	BRISTOL MYERS SQUIBB CO (BMY)
Mycophenolate mofetil	Filana Therapeutics Inc. (FLNA)
Mycophenolate Mofetil	Merus N.V. (MRUS)
Neratinib Maleate	ADMA BIOLOGICS, INC. (ADMA)
Nilotinib Hydrochloride Monohydrate	Relay Therapeutics, Inc. (RLAY)
Niraparib	Black Diamond Therapeutics, Inc. (BDTX)
novel hormonal therapy	PFIZER INC (PFE)
Olaparib	IGM Biosciences, Inc. (IGMS)
Olaparib	Relay Therapeutics, Inc. (RLAY)
Oleclumab	ASTRAZENECA PLC (AZN)
Pacritinib	Merus N.V. (MRUS)
Panitumumab	Relay Therapeutics, Inc. (RLAY)
Panitumumab	ADMA BIOLOGICS, INC. (ADMA)
PI3K-beta Inhibitor GSK2636771	Relay Therapeutics, Inc. (RLAY)
piflufolastat f 18	Novartis AG (NVS)
Piflufolastat F 18	Novartis AG (NVS)
pivekimab sunirine	ImmunoGen, Inc. (IMGN)
Ramucirumab	ELI LILLY & Co (LLY)
Ramucirumab	PTC THERAPEUTICS, INC. (PTCT)
SARS-CoV-2 mRNA Vaccine ARCT-021	Arcturus Therapeutics Holdings Inc. (ARCT)
Selumetinib Sulfate	ENANTA PHARMACEUTICALS INC (ENTA)
Selumetinib Sulfate	Relay Therapeutics, Inc. (RLAY)
Sotorasib	Relay Therapeutics, Inc. (RLAY)
Sotorasib	Merus N.V. (MRUS)
Sotorasib	ADMA BIOLOGICS, INC. (ADMA)
Sotorasib	ENANTA PHARMACEUTICALS INC (ENTA)
Tacrolimus	Assertio Holdings, Inc. (ASRT)
Tacrolimus	ENANTA PHARMACEUTICALS INC (ENTA)
Tacrolimus	Merus N.V. (MRUS)
Tagraxofusp	AbbVie Inc. (ABBV)
TAR-200	Janux Therapeutics, Inc. (JANX)
Temozolomide	ELI LILLY & Co (LLY)
Thiotepa	Merus N.V. (MRUS)
TIL	Filana Therapeutics Inc. (FLNA)
topotecan	BRISTOL MYERS SQUIBB CO (BMY)
Tozinameran	Arcturus Therapeutics Holdings Inc. (ARCT)
Tozinameran	ENANTA PHARMACEUTICALS INC (ENTA)
Tremelimumab	ADMA BIOLOGICS, INC. (ADMA)
Vinorelbine	ELI LILLY & Co (LLY)
Vinorelbine	PTC THERAPEUTICS, INC. (PTCT)

Phase 1(98)

Drug	Company
[68ga]ga-dwj155	Novartis AG (NVS)
Ami-HC	Structure Therapeutics Inc. (GPCR)
Ami-HC-CF	Structure Therapeutics Inc. (GPCR)
Ami-LC	Structure Therapeutics Inc. (GPCR)
Ami-LC-MD	Structure Therapeutics Inc. (GPCR)
Apalutamide	Merus N.V. (MRUS)
Apalutamide	Janux Therapeutics, Inc. (JANX)
aur107	PRF Technologies Ltd. (PRFX)
Avelumab	Accustem Sciences Inc. (ACUT)
aza-TdC	Arbutus Biopharma Corp (ABUS)
Belrestotug	ANAPTYSBIO, INC (ANAB)
BET Bromodomain Inhibitor ZEN-3694	Relay Therapeutics, Inc. (RLAY)
BI 836845	KYNTRA BIO INC. (KYNB)
Bridging Therapy	Janux Therapeutics, Inc. (JANX)
Cabazitaxel	Royalty Pharma plc (RPRX)
Cabazitaxel	Merus N.V. (MRUS)
Cabazitaxel	ARS Pharmaceuticals, Inc. (SPRY)
Cabazitaxel	Myovant Sciences Ltd. (MYOV)
cetrelimab	JOHNSON & JOHNSON (JNJ)
cetrelimab	Innovation Pharmaceuticals Inc. (IPIX)
Cetrelimab	Myovant Sciences Ltd. (MYOV)
Cetrelimab	ARS Pharmaceuticals, Inc. (SPRY)
Cobolimab	iTeos Therapeutics, Inc. (ITOS)
com503	COMPUGEN LTD (CGEN)
diphenhydramine	Sanofi (SNY)
dr30303	HCW Biologics Inc. (HCWB)
E7389-LF	ENANTA PHARMACEUTICALS INC (ENTA)
Edodekin alfa	ENANTA PHARMACEUTICALS INC (ENTA)
elacestrant	STEMLINE THERAPEUTICS INC (STML)
enfortumab vedotin	ELI LILLY & Co (LLY)
Enzalutamide	Janux Therapeutics, Inc. (JANX)
Eribulin	IGM Biosciences, Inc. (IGMS)
felmetatug vedotin	PFIZER INC (PFE)
GSK4418959	IDEAYA Biosciences, Inc. (IDYA)
GSK5764227	KYNTRA BIO INC. (KYNB)
GSK6097608	ANAPTYSBIO, INC (ANAB)
hdp-101	NYMOX PHARMACEUTICAL CORP (NYMXF)
hdp-101	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
idrx-42	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
Imlunestrant	ELI LILLY & Co (LLY)
jnj-101556143	GH Research PLC (GHRS)
jnj-1761981	JOHNSON & JOHNSON (JNJ)
jnj-1761981	Innovation Pharmaceuticals Inc. (IPIX)
jnj-69086420	GH Research PLC (GHRS)
jnj-75229414	GH Research PLC (GHRS)
JNJ-75229414	Filana Therapeutics Inc. (FLNA)
JNJ-75229414	Merus N.V. (MRUS)
JNJ-75229414	KYNTRA BIO INC. (KYNB)
JNJ-75229414	Janux Therapeutics, Inc. (JANX)
JNJ-78278343	Merus N.V. (MRUS)
JNJ-78278343	Janux Therapeutics, Inc. (JANX)
JNJ-78278343	Royalty Pharma plc (RPRX)
JNJ-78278343	KYNTRA BIO INC. (KYNB)
JNJ-78278343	Myovant Sciences Ltd. (MYOV)
JNJ-78278343	ARS Pharmaceuticals, Inc. (SPRY)
jnj-87704916	JOHNSON & JOHNSON (JNJ)
jnj-87704916	Innovation Pharmaceuticals Inc. (IPIX)
JNJ-87704916	Janux Therapeutics, Inc. (JANX)
jnj-88549968	GH Research PLC (GHRS)
jnj-89402638	GH Research PLC (GHRS)
jnj-95298177	GH Research PLC (GHRS)
JNJ-95298177	Janux Therapeutics, Inc. (JANX)
jnj-95437446	GH Research PLC (GHRS)
jnj-95804306	GH Research PLC (GHRS)
leucovorin	PFIZER INC (PFE)
LHRH agonist/antagonist	ELI LILLY & Co (LLY)
loxo-435	ELI LILLY & Co (LLY)
Lutetium Lu 177 Dotatate	Accustem Sciences Inc. (ACUT)
ly3484356	ELI LILLY & Co (LLY)
LY4214835	ELI LILLY & Co (LLY)
LY4257496	ELI LILLY & Co (LLY)
LY4337713	ELI LILLY & Co (LLY)
modakafusp alfa	Teva Pharmaceutical Industries Limited (TEVA)
naphazoline	Sanofi (SNY)
Niraparib	PTC THERAPEUTICS, INC. (PTCT)
PD-1 inhibitor	IDEAYA Biosciences, Inc. (IDYA)
Pemetrexed	IGM Biosciences, Inc. (IGMS)
Peposertib	Accustem Sciences Inc. (ACUT)
pf-08046050	PFIZER INC (PFE)
pf-08046052	PFIZER INC (PFE)
Pumitamig	Merus N.V. (MRUS)
QLH12016	KYNTRA BIO INC. (KYNB)
sar408701	Sanofi (SNY)
sar441000	Sanofi (SNY)
sar442257	Sanofi (SNY)
sar442257	Sanofi (SNYNF)
sar443216 iv	Sanofi (SNY)
sar443216 sc	Sanofi (SNY)
Selinexor	IGM Biosciences, Inc. (IGMS)
standard disease-directed therapy	Incyte Corp. (INCY)
TdCyd	Arbutus Biopharma Corp (ABUS)
Topotecan	ELI LILLY & Co (LLY)
Topotecan	IGM Biosciences, Inc. (IGMS)
Tucatinib	Merck & Co., Inc. (MRK)
Tuvusertib	Accustem Sciences Inc. (ACUT)
TVB-2640	KYNTRA BIO INC. (KYNB)
zamtocabtagene autoleucel	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
zimberelimab	COMPUGEN LTD (CGEN)

Preclinical(3)

Drug	Company
cpi-482	CONSTELLATION PHARMACEUTICALS INC (CNST)
ht-kit	Hoth Therapeutics, Inc. (HOTH)
JAK2 program	Cogent Biosciences, Inc. (COGT)

Unknown(3)

Drug	Company
Abiraterone acetate	Janux Therapeutics, Inc. (JANX)
et mono ± lhrh	Novartis AG (NVS)
et mono ± lhrh	NOVARTIS AG (NVSEF)

BLA Filed(1)

Drug	Company
sl-401	STEMLINE THERAPEUTICS INC (STML)

N/A(1)

Drug	Company
GLP-1 receptor agonist	ELI LILLY & Co (LLY)

Phase 1/Phase 2(15)

Drug	Company
[177lu]lu-nns309	Novartis AG (NVS)
cemiplimab regn2810	Sanofi (SNY)
CRN09682	Crinetics Pharmaceuticals, Inc. (CRNX)
dazostinag	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
dazostinag	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Enzalutamide	Arcus Biosciences, Inc. (RCUS)
jnj-63723283	GH Research PLC (GHRS)
nenocorilant	CORCEPT THERAPEUTICS INC (CORT)
pazopanib	GH Research PLC (GHRS)
Pumitamig	BioNTech SE (BNTX)
sar444200	Sanofi (SNY)
stro-002	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tisotumab vedotin	PFIZER INC (PFE)
vociprotafib	Sanofi (SNY)
vociprotafib	Sanofi (SNYNF)

Phase 2/Phase 3(2)

Drug	Company
[18f]ctt1057	Novartis AG (NVS)
iza-bren	BRISTOL MYERS SQUIBB CO (BMY)

Phase 4(22)

Drug	Company
abiraterone	PFIZER INC (PFE)
Abiraterone	KYNTRA BIO INC. (KYNB)
Abiraterone acetate	KYNTRA BIO INC. (KYNB)
Abiraterone acetate 250 mg or 500 mg tablets	KYNTRA BIO INC. (KYNB)
androgen deprivation therapy	GH Research PLC (GHRS)
Androgen receptor inhibitor	KYNTRA BIO INC. (KYNB)
Androgen Receptor Pathway Inhibitors	KYNTRA BIO INC. (KYNB)
Androgen Receptor Signal Inhibitor	KYNTRA BIO INC. (KYNB)
Androgen Receptor Signalling Inhibitor	KYNTRA BIO INC. (KYNB)
androgen-deprivation therapy	GH Research PLC (GHRS)
Androgen-deprivation Therapy	Janux Therapeutics, Inc. (JANX)
Apalutamide	KYNTRA BIO INC. (KYNB)
Bicalutamide	KYNTRA BIO INC. (KYNB)
bms-986213	BRISTOL MYERS SQUIBB CO (BMY)
Darolutamide	KYNTRA BIO INC. (KYNB)
Dexmedetomidine Injection [Precedex]	COGNITION THERAPEUTICS INC (CGTX)
Enzalutamide	Royalty Pharma plc (RPRX)
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)
niraparib	TESARO, Inc. (TSRO)
Olaparib	UNITED THERAPEUTICS Corp (UTHR)
Relatlimab	BRISTOL MYERS SQUIBB CO (BMY)
Xeloda	IGM Biosciences, Inc. (IGMS)

Compare drugs

elzonris vs levoleucovorin elzonris vs zaltrap elzonris vs 177lu-psma-617

Frequently asked questions

How many drugs are in development for Neoplasm?

BioSniper tracks 371 drugs in development for Neoplasm across 69 companies.

How many clinical trials target Neoplasm?

There are 7 clinical trials targeting Neoplasm tracked by BioSniper.

What is the prevalence of Neoplasm?

The estimated prevalence of Neoplasm is approximately 287.0 per 100,000 population.

Deep-dive into Neoplasm

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis